Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Adopting more systematic approaches to hepatitis C treatment in correctional facilities.

    Hammett TM.

    Ann Intern Med. 2003 Feb 4;138(3):235-6. No abstract available. PMID: 12558365 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Treatment for hepatitis C virus infection among inmates.

    [No authors listed]

    Ann Intern Med. 2003 Feb 4;138(3):I-50. No abstract available. PMID: 12558381 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Treatment of chronic hepatitis C in a state correctional facility.

    Bernstein D.

    Ann Intern Med. 2004 Jan 20;140(2):150-1; author reply 151. No abstract available. PMID: 14734350 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections.

    Berzin T, Allen S, Taylor L, Rich J, Feller E.

    Med Health R I. 2002 Nov;85(11):341-4. No abstract available. PMID: 12462866 [PubMed - indexed for MEDLINE]Related articles

    5.

    Economics of chronic hepatitis B and hepatitis C.

    Rajendra A, Wong JB.

    J Hepatol. 2007 Oct;47(4):608-17. Epub 2007 Jul 30. Review.PMID: 17697724 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hepatitis C: tackling the silent epidemic.

    Hamlyn AN.

    Br J Hosp Med (Lond). 2005 Oct;66(10):579-82. Review.PMID: 16255265 [PubMed - indexed for MEDLINE]Related articles

    7.

    Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.

    Wright M, Grieve R, Roberts J, Main J, Thomas HC; UK Mild Hepatitis C Trial Investigators.

    Health Technol Assess. 2006 Jul;10(21):1-113, iii.PMID: 16750059 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prevention and treatment of hepatitis C virus recurrence after liver transplantation.

    Garcia-Retortillo M, Forns X.

    J Hepatol. 2004 Jul;41(1):2-10. Review. No abstract available. PMID: 15246200 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting]

    Saiz de la Hoya-Zamácola P, Marco-Mouriño A, Clemente-Ricote G, Portilla-Sogorb J, Boix-Martínez V, Núñez-Martínez O, Reus-Bañuls S, Teixidó i Pérez N.

    Enferm Infecc Microbiol Clin. 2006 Nov;24(9):568-75. Spanish. PMID: 17125677 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Diagnosis, management, and treatment of hepatitis C.

    Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases.

    Hepatology. 2004 Apr;39(4):1147-71. No abstract available. Erratum in: Hepatology. 2004 Jul;40(1):269. PMID: 15057920 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

    Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

    Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.PMID: 15461877 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Treating hepatitis C in the prison population is cost-saving.

    Tan JA, Joseph TA, Saab S.

    Hepatology. 2008 Nov;48(5):1387-95. Review.PMID: 18924228 [PubMed - indexed for MEDLINE]Related articles

    13.

    New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C.

    Cornberg M, Manns MP.

    Ann Hepatol. 2005 Jul-Sep;4(3):144-50. Review.PMID: 16177653 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.

    Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ.

    JAMA. 2003 Jul 9;290(2):228-37.PMID: 12851278 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Goals of treatment, indication, and treatment for chronic hepatitis C]

    Paik SW.

    Korean J Gastroenterol. 2008 Jun;51(6):368-71. Review. Korean. PMID: 18604138 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C.

    Arguedas M.

    Pharmacoeconomics. 2004;22(7):477-8; author reply 478-9. No abstract available. PMID: 15137884 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment of hepatitis C. The 2002 French consensus.

    Dhumeaux D, Marcellin P, Lerebours E.

    Gut. 2003 Dec;52(12):1784-7. Review. No abstract available. PMID: 14633963 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.

    Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB; German Hepatitis C Model (GEHMO) Group; International Hepatitis Interventional Therapy (IHIT) Group.

    Gut. 2003 Mar;52(3):425-32.PMID: 12584228 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Antiviral treatment initiation costs in chronic hepatitis C.

    Siebert U, Wasem J, Rossol S, Sroczynski G, Aidelsburger P, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB.

    Gut. 2005 Jan;54(1):172-3. No abstract available. PMID: 15591531 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data